Supply chain resilience—the ability to withstand shocks, reorganize quickly, and maintain business continuity—has become a defining priority for pharmaceutical manufacturers.
Over the past years, the fragility of global API (Active Pharmaceutical Ingredient) supply chains has been exposed with unprecedented clarity.
Distributors of pharmaceutical raw materials now play a critical role in helping companies secure reliable sourcing, diversify risks, and navigate a rapidly shifting geopolitical and regulatory landscape.
This article explores why geographical presence matters, why China remains unavoidable, and how Safic-Alcan strengthens pharmaceutical supply chains through local expertise, regulatory capabilities, and business continuity planning.
Why Geography Matters When Choosing an API Distributor
For years, conversations about reshoring or relocating API production to Europe remained theoretical. Then COVID-19 reshaped the global pharmaceutical ecosystem almost overnight.
The pandemic highlighted several vulnerabilities:
- Heavy reliance on Chinese manufacturing for key intermediates and APIs
- Export restrictions in India during the first wave of 2020 to protect domestic supply
- European dependence on external production, especially highlighted by the paracetamol case, which reopened discussions on bringing strategic molecules back to Europe
It also became clear that reshoring API production—even if desirable—cannot fully solve the issue. The pharmaceutical industry has built decades-long supply networks where China plays a foundational role in chemical synthesis, intermediates, and cost-competitive API production.
Even today:
- China may not depend on Europe to supply its domestic market
- Europe remains highly dependent on China to support its pharmaceutical manufacturing
This is why reducing risk through smarter sourcing and partner selection often brings faster, more realistic resilience gains than attempting to overhaul the entire global manufacturing footprint.
Why Choose a Distributor Geographically Established in China?
Selecting a distributor with a local presence in China is now a key resilience strategy. It provides several competitive advantages:
A. Staying synchronized with a fast-paced ecosystem
China’s API and chemical ecosystems evolve rapidly. Local presence helps distributors understand regulatory updates, production movements, and early warning signals before they impact global supply.
B. Cost savings without relocating production
Bringing manufacturing back to Europe is expensive and often unfeasible. Maintaining reliable access to competitive, compliant Chinese suppliers helps companies stay profitable without compromising quality.
C. Deep regulatory knowledge
A local distributor understands documentation, audits, DMF processes, GMP expectations, environmental controls, and local regulatory shifts.
D. Cultural fluency and market understanding
Language, negotiation codes, relationship building, and trust are crucial in China. Local presence ensures clear communication, faster reaction time, and more reliable information.
In practice, this means pharmaceutical companies don’t need to build internal teams in China. Working with a distributor already established in the region provides immediate access to critical expertise and resources.
How Safic-Alcan Strengthens Your Supply Chain in China
As a global company with a local office in Chengdu, Safic-Alcan combines international standards with on-the-ground expertise. This enables us to actively reinforce supply chain resilience for pharmaceutical customers.
1. Double sourcing & business continuity planning
We help customers secure at least two—sometimes three—qualified sources for key APIs and intermediates. This reduces dependency on any single plant or region and ensures backup options in case of shortages, shutdowns, or logistical disruptions.
2. Direct access to trusted Chinese producers
Our established presence ensures strong relationships with compliant suppliers and immediate access to market intelligence, regulatory updates, and production shifts.
3. Strong regulatory expertise
Our teams understand local documentation requirements, audit preparation, DMFs, variation updates, and compliance expectations—critical for European and global pharmaceutical markets.
4. Cultural immersion & real-time communication
During the pandemic, when travel restrictions prevented companies from visiting suppliers, Safic-Alcan organized virtual plant meetings, technical discussions, and regulatory exchanges between Chinese producers and European customers.
This agility helped customers maintain visibility, develop business, and address concerns despite global disruptions.
5. Digital transformation to enhance responsiveness
Safic-Alcan’s digital tools enable fast communication, structured documentation, and efficient handling of customer inquiries—key assets for uninterrupted sourcing.
Conclusion: Your Partner in API Reshoring and Resilient Supply Chains
The pharmaceutical industry will continue facing global uncertainties, from pandemics to geopolitical tensions. Strengthening resilience is no longer optional—it is a long-term strategic requirement.
Safic-Alcan provides:
- Proven expertise in China and India
- Reliable sourcing strategies and backup suppliers
- Regulatory and technical support
- Local market intelligence and cultural insight
- Business continuity solutions tailored for API and raw material sourcing